Update
$Acurx Pharmaceuticals(ACXP.US$ Acurx Announces Positive Comparative Microbiology and Microbiome Data for Ibezapolstat from Phase 2b Clinical Trial in CDI Patients
4 MINUTES AGO, 7:01 AM EST
VIA PR NEWSWIRE![]()
4 MINUTES AGO, 7:01 AM EST
VIA PR NEWSWIRE
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
